Neonatal Jaundice

What is neonatal jaundice?

Neonatal jaundice is a common condition in newborn babies in which the skin and the whites of the eyes take on a yellow color. The yellow tint comes from a substance called bilirubin, a natural pigment produced when the body breaks down old red blood cells. In many newborns, bilirubin builds up faster than the baby’s immature liver can process and remove it, and the excess pigment settles in the skin and eyes.

To answer the question “what is neonatal jaundice” in the simplest terms: it is a visible sign that a newborn has a higher-than-usual level of bilirubin in the blood. Doctors call this hyperbilirubinemia, which simply means too much bilirubin circulating in the bloodstream. In medical coding systems, the general form of the condition is listed under ICD-10 code P59.9, meaning neonatal jaundice without a specified cause.

Neonatal jaundice affects a large proportion of newborns. It is seen more often in babies born prematurely (before 37 weeks of pregnancy), in breastfed babies during the first days of feeding, and in babies whose blood type differs from their mother’s in certain ways. In most cases the condition is mild, appears within the first few days of life, and fades on its own or with simple treatment. Less commonly, bilirubin can rise to levels that need prompt medical care, because very high levels can, in rare situations, affect a baby’s brain. This is why newborns are routinely checked for jaundice before leaving the hospital and at early follow-up visits.

Symptoms

The most recognizable neonatal jaundice symptoms involve a change in skin and eye color. Because newborn skin tones vary widely, the yellowing can be easier or harder to see depending on the baby’s natural coloring. In babies with darker skin, checking the whites of the eyes, the gums, and the skin after gentle pressure on the nose or forehead can help reveal the yellow tint.

Common signs parents and caregivers may notice include:

• Yellowing of the skin, usually starting on the face and forehead, then moving down toward the chest, belly, arms, and legs as bilirubin levels rise.
• Yellowing of the whites of the eyes (the sclera).
• Yellow tint to the gums or inside of the mouth, which can be helpful to check in babies with darker skin tones.
• Sleepiness or difficulty waking for feeds, in some babies with higher bilirubin levels.
• Poor feeding or weak sucking.
• Dark yellow urine (a newborn’s urine is normally almost colorless) or pale, clay-colored stools, which can point to less common liver-related causes.

The timing of symptoms matters and often reflects the type of jaundice:

Physiological jaundice is the most common form. It usually appears on the second or third day of life, peaks within the first week, and then gradually fades. It reflects the normal adjustment of a newborn’s liver and typically causes no lasting problems.

Breastfeeding-related jaundice can occur in the first week when a baby is not yet feeding well and takes in fewer calories and fluids. A separate pattern, sometimes called breast milk jaundice, can appear later and last for several weeks in otherwise healthy, well-fed breastfed babies; it is generally harmless but should still be reviewed by a doctor.

Jaundice within the first 24 hours of life is never considered routine. Early jaundice may signal a condition causing rapid breakdown of red blood cells, such as a blood group mismatch between mother and baby, and it needs urgent medical evaluation.

Prolonged jaundice, lasting beyond about two weeks in a full-term baby (or three weeks in a premature baby), also needs medical review, because in a small number of infants it can point to an underlying liver or metabolic condition.

Causes and risk factors

Understanding neonatal jaundice causes starts with how bilirubin is made and cleared. Before birth, the mother’s body helps remove bilirubin from the baby’s blood. After birth, the baby’s own liver must take over this job. Newborns also have more red blood cells than older children, and those cells have a shorter lifespan, so more bilirubin is produced at exactly the time the liver is still maturing. This mismatch between production and clearance explains why mild jaundice is so common in the first week of life.

Beyond this normal newborn physiology, several specific causes and risk factors can raise bilirubin further:

• Premature birth. Babies born before 37 weeks have less mature livers and often feed less effectively, both of which slow bilirubin removal.
• Blood group incompatibility. When the mother’s and baby’s blood types differ in certain ways (such as Rh or ABO incompatibility), the mother’s antibodies can cause the baby’s red blood cells to break down faster, producing more bilirubin.
• Feeding difficulties and dehydration. A baby who is not taking in enough milk passes fewer stools, and bilirubin that would normally leave the body in stool is reabsorbed instead.
• Bruising during birth. Significant bruising or a cephalohematoma (a collection of blood under the scalp from delivery) adds extra red blood cells that must be broken down, producing more bilirubin.
• Inherited red blood cell conditions. Certain inherited conditions, such as G6PD deficiency (a shortage of an enzyme that protects red blood cells), can make red cells break down more easily.
• Infection. Infections in a newborn can increase bilirubin levels and may need treatment in their own right.
• Liver and bile duct problems. Rarely, jaundice reflects a problem with the liver itself or with the bile ducts, the small tubes that drain bile from the liver. One example is biliary atresia, a rare blockage of the bile ducts that requires early diagnosis. These causes often produce a different laboratory pattern (a rise in “conjugated” or direct bilirubin, the form already processed by the liver) along with pale stools and dark urine.
• Family history and other factors. Having a previous sibling who needed treatment for jaundice, East Asian ancestry, and maternal diabetes have all been associated with a higher likelihood of significant jaundice.

It is important to note that in the majority of babies, jaundice is not caused by any disease at all. It is a temporary imbalance that resolves as feeding becomes established and the liver matures.

Diagnosis

Neonatal jaundice diagnosis begins with a physical examination. Doctors and nurses routinely check newborns for yellowing of the skin and eyes before hospital discharge and at early check-ups, ideally in good natural light. However, looking at the skin alone is not reliable enough to judge how high the bilirubin level actually is, so objective measurement is standard practice when jaundice is visible or suspected.

Tests commonly used to confirm and assess neonatal jaundice include:

• Transcutaneous bilirubin measurement. A small handheld device is gently pressed against the baby’s skin, usually on the forehead or chest, and estimates the bilirubin level through the skin without a needle. It is often used as a screening tool.
• Total serum bilirubin blood test. A small blood sample, often taken from the baby’s heel, measures the exact bilirubin level in the blood. This is the standard test used to guide treatment decisions.
• Interpretation against age-specific charts. Because bilirubin levels naturally rise and fall over the first days of life, doctors compare the result with charts (often called nomograms) that account for the baby’s age in hours, gestational age, and risk factors. The same number can be normal at one age and concerning at another.

If the jaundice appeared very early, is unusually severe, is rising quickly, or lasts longer than expected, your doctor may order additional tests to look for an underlying cause. These can include:

• Blood type and antibody testing for mother and baby, to check for blood group incompatibility.
• A complete blood count and reticulocyte count, to look for anemia or rapid red blood cell breakdown.
• A direct (conjugated) bilirubin level, to determine which form of bilirubin is elevated; a high conjugated fraction suggests a liver or bile duct problem.
• Tests for infection, when a baby appears unwell.
• G6PD enzyme testing, where an inherited red blood cell condition is suspected.
• Thyroid function tests and other metabolic screens, particularly in prolonged jaundice.
• Abdominal ultrasound, an imaging test using sound waves, if a bile duct blockage such as biliary atresia is being considered.

Most babies with typical, mild jaundice need only a bilirubin measurement and routine follow-up. The broader work-up is reserved for babies whose pattern of jaundice does not fit the usual, harmless picture.

Treatment options

Neonatal jaundice treatment depends on how high the bilirubin level is, how quickly it is rising, the baby’s age in hours, gestational age, and whether risk factors are present. The overall goal is simple: keep bilirubin below the levels at which it could pose a risk to the baby’s developing brain, while avoiding unnecessary intervention in babies who will improve on their own. In hospitals, newborn jaundice is generally managed by pediatric and neonatal teams; at Acibadem, for example, this falls within the Pediatrics department.

Watchful waiting and feeding support. For mild jaundice, the most common approach is careful observation with repeat bilirubin checks. Supporting frequent, effective feeding is a genuine treatment in itself: good milk intake helps the baby pass more stools, which is how much of the bilirubin leaves the body. For breastfed babies, this often means feeding on demand, typically eight to twelve times in 24 hours in the early days, sometimes with lactation support to improve latch and milk transfer. Routine supplementation with water or sugar water is not recommended, as it does not lower bilirubin and can interfere with feeding.

Phototherapy. When bilirubin reaches treatment thresholds, phototherapy is the standard first-line treatment. The baby is placed under special blue-spectrum lights (or on a light-emitting blanket or mattress) wearing only a diaper, with soft eye protection. The light changes bilirubin in the skin into forms the body can excrete in urine and stool without needing the liver to process it fully. Phototherapy is widely used, generally well tolerated, and usually continues until bilirubin falls to a safe level, with monitoring for temperature, hydration, and feeding throughout. Feeding usually continues during phototherapy, often with short breaks from the lights for feeds.

Intravenous fluids. If a baby is dehydrated or feeding poorly, your doctor may recommend fluids given through a vein alongside phototherapy while feeding is re-established.

Intravenous immunoglobulin (IVIG). In jaundice caused by blood group incompatibility, where the mother’s antibodies are breaking down the baby’s red blood cells, a medication called intravenous immunoglobulin may be given. It can reduce the rate of red cell breakdown and, in some cases, lessen the need for more intensive treatment.

Exchange transfusion. In the uncommon situation where bilirubin is very high or rising rapidly despite intensive phototherapy, doctors may perform an exchange transfusion. In this procedure, small amounts of the baby’s blood are gradually removed and replaced with donor blood, directly lowering bilirubin and removing the antibodies causing red cell breakdown. It is carried out in an intensive care setting and is reserved for severe cases because it carries more risk than phototherapy.

Treating the underlying cause. When jaundice is due to a specific condition, that condition is treated as well: antibiotics for infection, thyroid hormone for an underactive thyroid, and surgery for structural problems. Biliary atresia, for instance, is treated with an operation that must be performed early in life, which is one reason prolonged jaundice always deserves medical review. Surgery has no role in ordinary physiological or feeding-related jaundice.

Living with neonatal jaundice / outlook

For the great majority of newborns, the outlook is very good. Physiological and feeding-related jaundice typically resolve within one to two weeks in full-term babies, sometimes a little longer in premature infants or in breastfed babies with breast milk jaundice. Once the jaundice fades, most babies grow and develop normally, and the condition does not usually come back.

During the period when a baby is jaundiced, day-to-day care focuses on frequent feeding, watching the baby’s color, alertness, wet diapers, and stools, and attending all recommended follow-up appointments and bilirubin checks. Follow-up matters because bilirubin often peaks after many families have already gone home from the hospital, typically around days three to five of life.

The main concern with untreated, very high bilirubin is a rare condition called kernicterus, a form of brain damage caused when large amounts of bilirubin cross into the brain. Kernicterus can lead to long-term problems such as movement disorders and hearing loss. It is now uncommon in settings with routine newborn screening and timely treatment, and this is precisely why bilirubin monitoring and phototherapy thresholds exist. Honest framing is important here: while no one can guarantee an outcome in any individual baby, jaundice that is detected and treated according to standard guidelines rarely causes lasting harm.

Babies who needed intensive treatment, such as exchange transfusion, or who had a specific underlying disease may need additional follow-up, sometimes including a hearing test, as advised by their care team.

Frequently asked questions

What is neonatal jaundice and is it dangerous?

Neonatal jaundice is a yellowing of a newborn’s skin and eyes caused by a buildup of bilirubin, a pigment from the normal breakdown of red blood cells. In most babies it is a mild, temporary condition that fades on its own or with light therapy. It becomes dangerous only in the uncommon situation where bilirubin rises to very high levels without treatment, which is why routine checks and follow-up visits are so important.

How can I recognize neonatal jaundice symptoms at home?

Look for yellowing of the skin and the whites of the eyes, checking in good natural light. In babies with darker skin, the gums and the whites of the eyes are often the clearest places to check. Also watch feeding and alertness: a jaundiced baby who feeds poorly, is unusually sleepy, or has fewer wet diapers than expected should be seen by a doctor promptly rather than watched at home.

Does neonatal jaundice go away on its own?

In many cases, yes. Physiological jaundice usually fades within one to two weeks as the baby’s liver matures and feeding becomes established. However, whether a particular baby can safely wait depends on the bilirubin level and its trend, so this decision should always be made by a healthcare professional based on measurements, not appearance alone.

What is the main treatment for neonatal jaundice?

Phototherapy is the standard neonatal jaundice treatment when bilirubin reaches levels that need lowering. The baby lies under special lights that convert bilirubin in the skin into forms the body can excrete more easily. Milder cases are often managed with feeding support and repeat bilirubin checks, while very severe cases may need intravenous immunoglobulin or, rarely, an exchange transfusion.

Can I keep breastfeeding if my baby has jaundice?

In most cases, yes, and doctors generally encourage continued, frequent breastfeeding, because good milk intake helps the body remove bilirubin through stool. If feeding is not going well, lactation support or temporary supplementation may be recommended by your care team. Even in breast milk jaundice, which can last several weeks, breastfeeding usually continues under medical guidance.

Why does jaundice in the first 24 hours need urgent attention?

Jaundice that appears within the first day of life often signals rapid breakdown of red blood cells, for example from a blood group mismatch between mother and baby, rather than the normal newborn adjustment. Because bilirubin can rise quickly in these situations, early jaundice always needs prompt measurement and evaluation by a doctor.

Will jaundice affect my baby’s development later on?

For the vast majority of babies whose jaundice is monitored and treated when needed, there is no expected effect on long-term growth or development. Lasting problems are associated mainly with extremely high, untreated bilirubin levels, which are rare where newborn screening and phototherapy are available. If you have concerns about your baby’s development after significant jaundice, discuss follow-up options, including hearing assessment, with your pediatrician.

When to see a doctor

All newborns should have their skin checked and bilirubin assessed as recommended by their care team, usually before hospital discharge and again within the first days at home. Beyond routine checks, seek medical advice promptly if you notice any of the following red flags:

• Jaundice appearing within the first 24 hours of life.
• Yellowing that is spreading or deepening, especially reaching the arms, legs, palms, or soles.
• A baby who is very sleepy, difficult to wake, or floppy, or who feeds poorly or refuses feeds.
• A high-pitched cry, unusual irritability, arching of the back or neck, or any abnormal movements — these need emergency assessment.
• Fewer wet diapers than expected, signs of dehydration, or no stool for an unusual length of time.
• Pale, clay-colored stools or dark yellow urine, which can point to a liver or bile duct problem.
• Fever or any other sign that the baby seems unwell.
• Jaundice lasting longer than two weeks in a full-term baby, or three weeks in a premature baby.

When in doubt, it is always reasonable to have a jaundiced newborn checked. A simple, painless skin or blood test can quickly show whether the bilirubin level is safe, and early evaluation is the most reliable way to prevent the rare complications of untreated jaundice.